NKGen Biotech Inc [NASDAQ: NKGN] closed the trading session at $0.84.
The stocks have a year to date performance of 28.48 percent and weekly performance of 81.89 percent. The stock has been moved at -12.31 percent over the last six months. The stock has performed 71.80 percent around the most recent 30 days and changed 212.94 percent over the most recent 3-months.
If compared to the average trading volume of 531.18K shares, NKGN reached to a volume of 78940549 in the most recent trading day, which is why market watchdogs consider the stock to be active.
NKGN stock trade performance evaluation
NKGen Biotech Inc [NKGN] gain into the green zone at the end of the last week, gaining into a positive trend and gaining by 81.89. With this latest performance, NKGN shares gained by 71.80% in over the last four-week period, additionally sinking by -12.31% over the last 6 months – not to mention a drop of -48.04% in the past year of trading.
Overbought and oversold stocks can be easily traced with the Relative Strength Index (RSI), where an RSI result of over 70 would be overbought, and any rate below 30 would indicate oversold conditions. An RSI rate of 50 would represent a neutral market momentum. The current RSI for NKGN stock in for the last two-week period is set at 73.20, with the RSI for the last a single of trading hit 80.29, and the three-weeks RSI is set at 67.98 for NKGen Biotech Inc [NKGN]. The present Moving Average for the last 50 days of trading for this stock 0.5319, while it was recorded at 0.4950 for the last single week of trading, and 0.7926 for the last 200 days.
NKGen Biotech Inc [NKGN]: An insightful look at the core fundamentals
NKGen Biotech Inc’s liquidity data is similarly interesting compelling, with a Quick Ratio of 0.02 and a Current Ratio set at 0.02.
NKGen Biotech Inc [NKGN]: Institutional Ownership
There are presently around $17.26%, or 28.48%% of NKGN stock, in the hands of institutional investors.
